
Corgone 200mg Tablet SR
Marketer
Sykocure Lifesciences
Salt Composition
Carbamazepine (200mg)
Overview Corgone 200mg Tablet SR
Epileptic seizures and certain neuropathic pain conditions are managed with the extended-release Corgone 200mg tablet. This medication is effective in preventing seizures and alleviating the pain of trigeminal neuralgia and diabetic neuropathy. Administer this medication consistently, at the same time daily, with or without food, as directed by your physician. Dosage adjustments will be determined individually to optimize symptom control and may be increased gradually. Concurrent medication use requires disclosure to your doctor to ensure safety and avoid interactions. Regular daily intake is crucial for maximum therapeutic effect, and discontinuation should be gradual to prevent seizure recurrence or worsening of your condition. Common side effects encompass nausea, vomiting, dizziness, somnolence, gait instability, constipation, dry mouth, and pruritus; blurred vision and dysarthria may also occur. While most side effects are mild, promptly report skin rashes, mood changes, or suicidal ideation. Prior to commencing Corgone 200mg, inform your doctor of any pre-existing cardiac, renal, hepatic, or urinary issues, or mental health conditions, as these factors can influence treatment. Regular blood tests (e.g., complete blood count) may be recommended to monitor treatment efficacy.
Uses of Corgone 200mg Tablet SR
Nerve damage in diabetes | Trigeminal neuralgia | Seizure disorders
Major Benefits of Corgone 200mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Corgone 200mg Sustained-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Corgone 200mg Tablet SR:
- Dizziness
- Nausea
- Vomiting
- Constipation
- Sleepiness
- Abnormality of voluntary movements
How to use Corgone 200mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Corgone 200mg Extended-Release Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Corgone 200mg Tablet SR works:
Corgone 200mg sustained-release tablets are used to manage epilepsy. This medication works by reducing the overactive electrical signaling in brain neurons, thus controlling seizures.
SAFETY ADVICE
AlcoholUNSAFE
Taking Corgone 200mg extended-release tablets with alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Corgone 200mg tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. Exceptions might exist in critical circumstances where a physician deems the potential benefit outweighs the risk to the mother. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Corgone 200mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Prolonged-release Corgone 200mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Corgone 200mg sustained-release tablets in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Corgone 200mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Corgone 200mg Tablet SR :
Should you forget a Corgone 200mg Tablet SR dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Corgone 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Stilbene Imine Derivative |
| Developing Habits | No. |
| Type of Treatment | Central Nervous System (CNS) Neurology |
